In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation

Abstract Background Fibroblast activation protein (FAP) is an attractive target for cancer theranostics. Although FAP-targeted nuclear imaging demonstrated promising clinical results, only sub-optimal results are reported for targeted radionuclide therapy (TRT). Preclinical research is crucial in se...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Circe D. van der Heide, Joana D. Campeiro, Eline A. M. Ruigrok, Lilian van den Brink, Shashikanth Ponnala, Shawn M. Hillier, Simone U. Dalm
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	SpringerOpen 2024-12-01
Sarja:	EJNMMI Research
Aiheet:	Cancer-associated fibroblast (CAF) Fibroblast activation protein (FAP) Targeted radionuclide therapy (TRT) Radionuclide theranostics Preclinical models
Linkit:	https://doi.org/10.1186/s13550-024-01191-6
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!